TABLE 1.

V1-V2 length and number of PNGS during early versus chronic infection

SubjectValue for indicated infection phase
EarlyChronic
Infection intervala (mo)No. of sequencesbV1-V2 medianPNGS medianInfection intervala (mo)No. of sequencesbV1-V2 medianPNGS median
QA2031146154111596
QA2841156034712606
QA7792175743719575
QB424121615311273.56
QB5966166152416625
QB670110716461272.56
QC1681136163210616
QC4495167774116777
QC8902168084214767
  • a Duration from estimated date of infection to day of sample collection.

  • b Number of independent sequences analyzed.